Genmab Q4 EPS $0.05 Misses $0.44 Estimate, Sales $1.058B Miss $4.401B Estimate
Genmab (NASDAQ:GMAB) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.44 by 88.64 percent. This is a 94.12 percent decrease over earnings of $0.85 per share from the same
